MedTrace Logo

Treat Primary and Metastatic Liver Tumors

NCT05240040 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-03-23

No results posted yet for this study

Summary

The use of Radiospheres in the management of intrahepatic cholangiocarcinoma is largely unknown and not reported in the medical literature. Methodist Dallas Medical Center has a large volume of IR procedures with Radioembolization and the investigators feel it is imperative to understand the outcomes, risks and benefits of the therapy in order to formulate recommendation to other centers.

Conditions

  • Intrahepatic Cholangiocarcinoma
  • Liver Tumor
  • Metastatic Cancer
  • Metastatic Liver Cancer

Sponsors & Collaborators

  • Methodist Health System

    lead OTHER

Principal Investigators

  • Alejandro Mejia, MD · The Methodist Hospital Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-26
Primary Completion
2022-02-28
Completion
2022-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05240040 on ClinicalTrials.gov